Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: Comprehensive analysis pinpoints CCNA2 as a prognostic and immunological biomarker in non-small cell lung cancer

Fig. 3

CCNA2 correlated with clinicopathological features in NSCLC. Relationship between CCNA2 expression and clinical stage of LUAD (A) and LUSC (B). Relationship between CCNA2 expression and lymph node metastasis of LUAD (C) and LUSC (D). Relationship between expression of CCNA2 and TP53 mutant of LUAD (E) and LUSC (F). * P < 0.05; ** P < 0.01; *** P < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us